AZB & Partners Advised SCHOTT Pharma On TPG Scion’s Acquisition In SCHOTT Poonawala

May 12, 2025

AZB & Partners acted for SCHOTT Pharma in connection with TPG Scion Unit Trust’s acquisition of 35% stake in SCHOTT Poonawala Private Limited (SCHOTT Poonawala) from Serum Institute of India Private Limited (SII). SCHOTT Poonawalla Pvt Ltd is a joint venture of SCHOTT Pharma and SII, which is part of the Cyrus Poonawalla Group.

The AZB deal team comprises of our Senior Partner Daksh Trivedi, Partner Aman Jain and Associates Sarthak Sharma and Srishti Kaushal, and on the Competition aspects by our Senior Partner Hemangini Dadwal.

Aman Jain, Daksh Trivedi, Hemangini Dadwal, Sarthak Sharma, Srishti Kaushal

Pharma & Healthcare

Mergers & Acquisitions

The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at connect@thedealmatter.com mentioning your firm’s name, lawyers involved (including designation) and client represented.